Reuben Ehrlich

Reuben Ehrlich has a diverse work experience spanning over two decades. Reuben started their career as an Analyst at Searle in 2000 and later founded their consulting firm, Ehrlich Consulting Services, Inc. in 2001. In 2005, they joined TAP Pharmaceuticals as a Market Research Manager. Reuben then worked at Roche Pharmaceuticals and Roche Laboratories as a Project Manager from 2007 to 2009. Reuben moved to Forest Laboratories as a Senior Manager of New Products in 2009 before joining IKARIA, Inc. as an Associate Director of Market Analytics. Mallinckrodt Pharmaceuticals acquired IKARIA, Inc., and Reuben continued their journey at Mallinckrodt as a Senior Director of Decision Analytics & Insights. At Mallinckrodt, they held various roles, including Director of Market Research and Executive Director of Data & Insights. In 2022, Reuben joined Lumanity as the Executive Vice President, Quantitative Research and Forecasting Lead. Currently, they are serving as the Head of Market Analytics and Insights at Syndax Pharmaceuticals, starting in 2023. Throughout their career, Reuben demonstrated expertise in market analytics, insights, and strategic planning, contributing to the growth and success of the organizations they have been a part of.

Reuben Ehrlich completed an MBA degree with a focus on Marketing, Health Industry Management, and Strategy from Northwestern University's Kellogg School of Management from 1999 to 2001. Prior to that, they obtained a Bachelor of Arts degree in Sociology and History from Texas A&M University, where they studied from 1991 to 1994. In addition to their formal education, Reuben has earned a certification in Unconscious Bias V3.1 from Traliant in the year 2022.